Fact CheckerSign in

NCT05686122Completed

Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings (PainPac)

Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings

Source: ClinicalTrials.gov · Last updated 4 Sept 2025

Brief summary (registry, in English)

PainPac is innovative in its potential to integrate with healthcare systems through electronic medical records (EMRs). PainPac leverages technology to increase patient access to interventions and uses real-time assessment to improve care. PainPac is positioned to rapidly provide improved care through combining biological data (e.g., EMRs, patient collected) with behavioral data to dramatically improve outcomes. PainPac could track beneficial outcomes related to clinical pain scores (e.g., patients with scores 4-8 benefit) and intervention implementation could be based on this; a more advanced possibility is use of geospatial tracking to predict space/time where pain is likely to impact functioning and push an intervention strategy - behavioral or pharmacological. PainPac is designed for future transmission of data to EMRs to inform providers of patient status. This work will provide data to bypass traditional efficacy trials and move quickly to a large effectiveness trial.

Status (registry)
Completed
Study type
Interventional
Enrollment
62 (actual)
First submitted
6 Jan 2023
Start date
Sept 2023
Primary completion date
Oct 2024
Lead sponsor
Duke University
NCT number
NCT05686122

What you commit to

  • Study type: Interventional
  • Participants enrolled: 62
  • From Sept 2023 to the primary completion date, Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cognitive Impairment
  • Severe psychiatric condition (e.g., psychosis) that would contraindicate safe participation

Other

  • Brain Metastases
  • Participation in behavioral pain management in the past 6 months.

Who the study is looking for

  • Stage I-IV Colorectal Cancer diagnosis
  • 18 years of age or older

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Duke Cancer Institute
Coordinator of this site? Confirm its status
DurhamUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.